Curtin-led meta-analysis links type 2 diabetes to 53% higher Alzheimer's risk

A Curtin University-led systematic review and meta-analysis of 40 studies reported that adults living with type 2 diabetes had a 53% higher adjusted relative risk of developing Alzheimer's disease than adults without type 2 diabetes. The review, published in Alzheimer's Research & Therapy, also estimated that among 1,000 people with type 2 diabetes followed for one year, an average of 4.7 would receive an Alzheimer's diagnosis.

The analysis separated incidence from relative risk. Incidence describes new cases in a population over time; relative risk compares the rate between groups. The authors said earlier reviews often combined diabetes types or dementia subtypes, making the absolute burden harder to interpret. By focusing on type 2 diabetes and Alzheimer's disease, they reported both the 53% adjusted relative increase and the year-one incidence estimate of 4.7 cases per 1,000 people with diabetes.

The finding fits a broader pattern in chronic disease research: metabolic conditions and neurodegeneration are linked through pathways that can include vascular injury, insulin signaling, inflammation and shared risk factors such as age and obesity. It does not establish that type 2 diabetes causes Alzheimer's. The 53% figure is an adjusted relative risk, which can shrink or widen depending on which factors are controlled, and the 4.7 per 1,000 figure reflects the pooled populations studied, not every setting.

For aging populations, the public health relevance is large because type 2 diabetes is common and Alzheimer's disease is among the leading causes of disability and dependency. The evidence quality is that of a meta-analysis of observational studies: it can strengthen the association between type 2 diabetes and Alzheimer's incidence, but it cannot prove causation. A decisive next step would be randomized or quasi-experimental evidence testing whether diabetes prevention or treatment changes Alzheimer's outcomes.